Next pegged blockbuster arrives

Posted 12 April 2024 AM

A heart drug expected to be an era-defining blockbuster for MSD, which was until recently called sotatercept, is among six new drugs that officially landed in Australia.

An update to the TGA's list of drugs under evaluation shows the pulmonary arterial hypertension treatment was accepted under priority review and orphan status within weeks of the FDA's approval of the drug under the brand name Winrevair.

To see the whole article, please login